Lemercier Jean-Luc M
Known title: CVP, EMEA, Canada, Latin AmerCIK: 0001710625
Associated companies
Transaction History
| EW | ▼ Sell | Tax Withholding | 82 | $8K | 7/7/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 21 | $2K | 5/11/2024 | View on chart |
| EW | ▲ Buy | Grant | 7,125 | $0 | 5/7/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 46 | $4K | 5/7/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 259 | $22K | 5/6/2024 | View on chart |
| EW | ▲ Buy | Option Exercise | 4,157 | $0 | 5/4/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 37 | $3K | 5/3/2024 | View on chart |
| EW | ▲ Buy | Option Exercise | 14,400 | $529K | 5/1/2024 | View on chart |
| EW | ▼ Sell | Open Market | 2,160 | $183K | 5/1/2024 | View on chart |
| EW | ▼ Sell | Open Market | 12,240 | $1.0M | 5/1/2024 | View on chart |
| EW | ▲ Buy | Option Exercise | 14,400 | $529K | 4/8/2024 | View on chart |
| EW | ▼ Sell | Open Market | 107 | $10K | 4/8/2024 | View on chart |
| EW | ▼ Sell | Open Market | 14,293 | $1.3M | 4/8/2024 | View on chart |
| EW | ▲ Buy | Option Exercise | 14,400 | $529K | 3/11/2024 | View on chart |
| EW | ▼ Sell | Open Market | 14,400 | $1.3M | 3/11/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 81 | $7K | 7/7/2023 | View on chart |
| EW | ▲ Buy | Grant | 1,575 | $0 | 5/11/2023 | View on chart |
| EW | ▲ Buy | Option Exercise | 6,640 | $234K | 5/9/2023 | View on chart |
| EW | ▼ Sell | Open Market | 6,640 | $589K | 5/9/2023 | View on chart |
| EW | ▼ Sell | Tax Withholding | 104 | $9K | 5/8/2023 | View on chart |
| EW | ▲ Buy | Option Exercise | 3,355 | $0 | 5/7/2023 | View on chart |
| EW | ▼ Sell | Tax Withholding | 224 | $20K | 5/7/2023 | View on chart |
| EW | ▼ Sell | Tax Withholding | 38 | $3K | 5/4/2023 | View on chart |
| EW | ▼ Sell | Tax Withholding | 37 | $3K | 5/3/2023 | View on chart |
| EW | ▲ Buy | Option Exercise | 6,640 | $234K | 4/6/2023 | View on chart |
| EW | ▼ Sell | Open Market | 6,640 | $552K | 4/6/2023 | View on chart |
| EW | ▲ Buy | Option Exercise | 6,640 | $234K | 3/8/2023 | View on chart |
| EW | ▼ Sell | Open Market | 50 | $4K | 3/8/2023 | View on chart |
| EW | ▼ Sell | Open Market | 6,590 | $507K | 3/8/2023 | View on chart |
| EW | ▲ Buy | Grant | 6,100 | $0 | 7/7/2022 | View on chart |
| EW | ▼ Sell | Tax Withholding | 143 | $14K | 5/17/2022 | View on chart |
| EW | ▲ Buy | Option Exercise | 11,560 | $252K | 5/9/2022 | View on chart |
| EW | ▼ Sell | Open Market | 11,560 | $1.1M | 5/9/2022 | View on chart |
| EW | ▼ Sell | Tax Withholding | 615 | $62K | 5/8/2022 | View on chart |
| EW | ▲ Buy | Option Exercise | 8,531 | $0 | 5/8/2022 | View on chart |
| EW | ▼ Sell | Tax Withholding | 51 | $5K | 5/7/2022 | View on chart |
| EW | ▼ Sell | Tax Withholding | 42 | $4K | 5/4/2022 | View on chart |
| EW | ▲ Buy | Grant | 2,750 | $0 | 5/3/2022 | View on chart |
| EW | ▲ Buy | Option Exercise | 11,660 | $254K | 4/8/2022 | View on chart |
| EW | ▼ Sell | Open Market | 100 | $12K | 4/8/2022 | View on chart |
| EW | ▼ Sell | Open Market | 11,560 | $1.4M | 4/8/2022 | View on chart |
| EW | ▲ Buy | Option Exercise | 11,660 | $254K | 3/11/2022 | View on chart |
| EW | ▼ Sell | Open Market | 5,125 | $546K | 3/11/2022 | View on chart |
| EW | ▼ Sell | Open Market | 6,535 | $690K | 3/11/2022 | View on chart |
| EW | ▲ Buy | Option Exercise | 100 | $2K | 11/29/2021 | View on chart |
| EW | ▼ Sell | Open Market | 100 | $11K | 11/29/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
EW: FDA Flags High-Risk Device Recall After Patient Death
The U.S. Food and Drug Administration flagged a potentially high-risk issue with Edwards Lifesciences' SAPIEN M3 delivery system, specifically the Commander M system, after a patient death was reported. The company has instructed customers to remove four specific lots of the device from use. This regulatory action highlights a significant safety concern for the company's key product line, drawing close regulatory scrutiny.
EW: FDA Flags High-Risk Device Recall After Patient Death. The U.S. Food and Drug Administration flagged a potentially high-risk issue with Edwards Lifesciences' SAPIEN M3 delivery system, specifically the Commander M system, after a patient death was reported. The company has instructed customers to remove four specific lots of the device from use. This regulatory action highlights a significant safety concern for the company's key product line, drawing close regulatory scrutiny.